Contact
Please use this form to send email to PR contact of this press release:
ReEngage Therapeutics Joins Texas Medical Center’s 2025 Accelerator for Cancer Therapeutics
TO:
Thomas Kim
ReEngage Therapeutics Inc.
+1 215-400-0133